Inherited giant platelet disorders are a heterogeneous group of disorders. In the current study, a patient was reported with moderate bleeding tendency, giant platelets, and spontaneous platelet aggregation, which were not affected by the administration of aspirin or ticlopidine. The electron microscopy of platelets showed a black and thick plasma membrane with crystal-like fine hairs in the exterior coat and more large and variously shaped granules in the cytoplasm. The ex-pression of glycoprotein (GP) Ib, GP IIb, and GP IIIa on platelet surface was normal, and no mutations in genes for GP Ib&alpha;,
GP Ib&beta;, and GP IX were detected. These phenomena are so distinguishable from those of Mondreal platelet syndrome and other hereditary giant platelet disorders, that we propose that this patient probably has a novel platelet disorder, which has not yet been reported. Key Words: Platelet&mdash;Aggregation, spontaneous&mdash;Membrane&mdash;Glycoprotein&mdash;Granule&mdash;Gene.
Spontaneous platelet aggregation (SPA) is associated ; with either acquired platelet function change or heredi-' tary platelet disorders. The acquired SPA may occur under many circumstances. One of the most common is . ethylenediaminetetraacetic acid (EDTA)-dependent lat~l~t antibodies ( I1). In addition, hypersensitive platelets are often seen in a number of disease states, especially cardiovascular diseases, including myocardial infarction, angina, stroke, and peripheral vascular disease, which could cause SPA (2) (3) (4) . Myeloproliferative disorders also appear to induce SPA (5) . Inheritec~ giant platelet disorders are a heterogeneous group of disorders in-, volving glycoprotein (GP) abnormalities, granule defects, or other clinical or morphologic findings, including ' Bcmard-Souiier syndrome ~(BSS) (6,7), gray platelets syndrome (8) , and l~I~;~~-He~~Iin anomaly (9~. Platelet aggregation in disorders is either normal or reduced, but SPA is found, in Mondreal platelet syndrome ~~~~~t Platelet syndromes is a rare hereditary platelet characterized by thrombocytopenia, giant platelets, and a bleeding tendency. Spontaneous platelet aggregation is the prominent feature of this disorder, and could even occur in a calciumfree and fibrinogen-free condition (10, 11) . The patho-genesis of MPS is still unknown. A reduction in the platelet surface GP Ib and in the content of the sialic acid was found only in one patient (10) . Okita et ail. (12) reported a defect in both the antigen and the activity of calcium-activated neutral proteinase (calpain) in MPS platelets. However, Okita et al. (12) did not perform the gene analysis. Recently, we found a patient who had a mild bleeding diathesis early in life, giant platelets, and remarkable SPA. Some of platelet morphologic features and laboratory abnormalities of this patient could exclude a diagnosis of MPS or other related diseases, and we think she has a novel congenital giant platelet disorder which, to our knowledge, has not been reported in the literature.
MATERIALS AND METHODS

Patient .
The patient was an 11-year-old girl with a moderate purpuric manifestation in the skin and rare nose bleeding for 6 years. In laboratory examinations, her routine coagulation tests were normal, with factor VIII-~C being 90%. Her automated platelet count ranged between 80 and 90 x 10~/L. The platelets displayed a remarkable variation in size; some of them were giant (mean platelet volume [MPV] 18.8 fL, normal 7 to 11 'fL), with the largest platelet being 6 ~m in diameter. The blood smear showed many large granules in the platelets and a significant proportion (more than 50%) of platelets in microaggregates containing a various number (3 to 3.~(~) . of platelets ( Fig. 1 ). This spontaneous aggregation was not inhibited by antiplatelet drugs such as aspirin (100 ng per day) and ticlopidine (250 mg per da~~. 51i~ had no thrombotic complications at any time. Examination of smears made from bone marrow aspirate showed a number of normal megakaryocytes. Bleeding time was 17 minutes (normal range, 4 to 8 minutes). Her parents were not consanguineous, and their platelet counts were normal without platelet aggregates found on blood film. Informed consent for the study was given in accordance with the Declaration of Helsinki.
Blood sample preparation
Blood was drawn by venipuncture into 3:8°~~ sodium citrate (vol:vol, 9:1). Platelet-rich plasma (PRP) was obtained by spontaneous sedimentation, because the large size and clumping of the platelets made it technically difficult to prepare PRP by centrifugation. Platelet aggregation was turbidometrically measured. The remaining blood was centrifuged to prepare platelet-pool plasma (PPP) (13) and the leftover blood was kept at -40°C for gene analysis until assay.
Electron microscopy
The PRP sample was combined with an equal volume of 0.1% glutaraldehyde in phosphate-buffered saline (PBS) to sediment at 37°C for 15 minutes (14) . The supernatant was fixed in 3% glutaraldehyde at 4°C for 60 minutes. The cells were washed, then combined with I ~lo osmic acid and dehydrated in a graded series of alcohol and embedded in par Observation was made by electron microscopy (H600, Hitashi Ca.; Tokyo, Japan). ulti~~ric analysis of plasma von '4~i~~~r~~a~ factor A modification of the discontinuous buffer system of Ruggeri was used (15) . The aminetetraacetic acid (Na2), 2% SDS, and Cl.~~'~~a bromophenol blue. Forty microliters of diluted plasma sample was applied to each well and electrophoresed through this system for 16 hours. Then the gel ways fixed, and reacted overnight with 12:51-labeled anti-von factor monoclonal antibody (MAb) SZ29, which was produced in our institute. Finally, the gel was washed and dried, and then the autoradiography was performed.
Flow cytometry
The following MAb to platelet GPs were used: SZ2 against GP Ib a, SZ22 against GP lib, SZ21 against GP nia, and SZ51 against P-selectin, which were all products of our institute. Fluorescein isothiocyanate (FITC)conjugated F(ab ' )~ fragment of goat anti-mouse immunoglobulins was purchased from Immunotech (Marseilles, France). Fifty microliters whole blood was incubated in plastic wells with 10 {jbL (0'.2 pg) of each MAb for 1 hour (16) . Unrelated mouse immunoglobulin was used a negative control. The blood was washed twice with PBS, resuspended, and incubated for 60 mainutes with 20 ~LL FITC-conjugated goat anti&reg;rnc~use'in~munoglobulin F(ab)2, which was diluted to 1:20, 20 Lg/mL. After washing twice with PBS to remove unbound antibody, the platelets were fixed in 2% formaldehyde in the buffer. At least 10,000 gated platelets were analyzed by exciting the FITC label at 480 nm using an argon laser, and evaluated emission at 520 nm using flow cytometry (Epies-XL, Coulter Co., Miami, FL, USA).
Polynierase chain reaction Genonic deoxyribonucleic acid (DNA) was extracted from the blood sample. The entire lengths of DNA encoding open reading frames of GP Ib<x, GP Ibp and GP IX genes were amplified by polymerase chain reaction Co., Foster City, CA, USA), with the amplification primer used as sequencing primers.
RESULTS
Platelet aggregation
No platelet aggregations were induced in response to 5 >M adenosine diphosphate (ADP), 200 p.g/mL, arachidonic acid, 5 pM A23187, or 1.25 mg/mL ristocetin, probably because the platelets had already so preaggregated that no further change in light transmission could be observed after adding these aggregating agents.
Ultrastructures Figure 2 demonstrates the platelet ultra~tructure of the patient under electron microscope. The platelets were giant, and their plasma membrane appears especially dark and thick, with some crystal-like &dquo;villi&dquo; in the exterior coat. The cytoplasm contains more large, round, rod-and &dquo;cigar&dquo;-shaped granules. Like on the blood smear, platelet aggregates in a variety of sizes were easily found.
Plasma von Willebrand factor multimer analysis von Willebrand factor multimer of the patient's plasma in SDS-agarose ~l~ctroph~r~sis showed a com- plex series of bands including low-,intermediate-, and high-molecular-weight muttimers, and was normal multimer pattern, while the plasma from a patient with type 2A von VVil6ebr~r~d disease showed characteristic loss of high and intermediate molecular multimers (20) (Fig. 3 ).
Ftoweytometry
Flow cytometic analysis of the patterns platelets is shown in Figure 4 . Both cell-positive percentage and the mean fluorescence intensity of GP Ib, GP Ilb, GP Illa, and P-selectin were found in essentially normal-amounts on platelet surface of the patient, compared with those of a control subject.
Mutation analysis
To identify whether the patient had genetic abnormalties of the GP Ib/IX complex, as in another hereditary giant platelet disorder, Bemard-Souiier syndrome, the entire coding regions of GP Iba gene, GP Ib(3 gene, and GP IX gene were amplified and direct DNA sequence analyzes were performed. No gene mutations were detected.
DISCUSSION
The patient reported in this study meets the criteria for the diagnosis of congenital giant platelet disorders: large platelets and bleeding symptoms from early in life (11) . One off the most specific characteristics off her platelets was SPA. It was not possible that the platelet aggregates or clumping were formed in improperly prepared films because this phenomenon was confirmed in four different hospitals. Platelet clumping is most commonly caused by the EDTA anticoagulant (21) , which was occasionatty associated with antiphospholipid antibodies (22) and in hospitalized, severely ill individuals (23) . However, in this patient, results of immunologic meai FIG.4. Fluorescence histograms of platelet membrane glycoprotein (GP) 16 , GP lib, GP Ota, and P-selectin from the patient (A) and from ! a healthy individual (B). The figures in parenthesis show mean positive cell percentage. The expression of these GPs on platelet surface ' : of the patient is almost the same as that of a healthy individual. surements, including antinuclear antibody, antiphospho-lipid antibody, complement immune complex, and platelet-associated immunoglobulin, were either negative or within the normal range (data not shown). In addition, no significant difference was observed between platelet counts in citrate (80 x 109/L) and in EDTA (89 x 109/L), suggesting that the SPA would obviously be unrelated to EDTA-dependent antibodies. It was also demonstrated that normal platelets resuspended in the patient' PPP did not undergo SPA, whereas the patient's platelets resuspended in normal PPP continued to show SPA. This observation could exclude the possibility that a plasma abnormality results in SPA in this case. Acquired SPA was also reported in cardiovascular diseases (2.-4) and myeloproliferative disease (5) , which could be ruled out from the diagnosis because of her young age and normal bone marrow examination.
Another specific characteristic off this case is giant platelets. George (24) recently indicated that truly giant platelets approaching the diameter of red cells occur only in congenital disorders. As mentioned above, inherited giant platelet disorders are a heterogeneous group of disorders, most of which were discovered within the last decade (11) . In general, platelet aggregation in these disorders is either normal or reduced and SPA never could occur, with the exception of MPS. In the latter, platelets undergo spontaneous aggregation and stir-induced microaggregate formation. However, the morphologic features and laboratory abnormalities of this patients platelets are different from those of MPS. First, the MPS platelet aggregates are very small, containing only two to six platelets, though on occasion much larger aggregates could be observed. The addition of ADP, adrenaline, collagen, ionophore A23187, and ristocetin increase MPS platelet aggregation, and the increase in platelet aggregation induced by these agents when corrected for SPA is similar to that observed for normal platelets in the same platelet count. The increase in SPA could be inhibited by prostaglandin E , aspirin, and partially by apyrase (10) . In our patient, much larger (more than 100 platelets) platelet aggregates were easily found, which were not affected by administration of aspirin or ticlopidine, and further platelet aggregation could not be ob-' served in the presence of agents. Second; the count in MPS was remarkably reduced (30 to 70 x 10~/L), with moderately large platelets (3 pm in diam-, eter), platelet ultrastmctural features within normal lim-! its, and granules in normal number (10) . In our patient., a ! moderately low platelet number in automated platelet ! counting was a spurious phenomenon due to SPA. Ex-! animation of the peripheral blood smear could confirm / the platelet count to be within the normal range. More-& d q u o ; over, platelets showed a great variation in size, with the / largest being 6 >m in diameter, and contained numerous I large granules. Third, the platelet ultrastructure of our patient showed thick membrane and numerous large granules in different shapes. These characteristic mor-phc~lc~gic changes have never been reported in MPS. It was certainly not a technical artifact, because they had not been fcaund in our previous electron microscopic study of a number of platelet specimens. Therefore, it is difficult to establish the diagnosis of this case as MPS.
There is another platelet disorder, platelet-type von Willebrand disease (or pseudo-von Willebrand disease) (25, 26) , to be considered in differential diagnosis. Platelets of platelet-type von Willebrand disease have an increased ability to bind to von Willebrand factor due to genetic abnormality in von Willebrand factor-binding site of OP Iba, resulting to a high sensitivity to ristocetin-induced platelet agglutination and a decrease in plasma levels of high-molecular-weight von Willebrand factor. However, SPA does not appear in any case with platelet-type von Willebrand disease. In our patient, the von Willebrand factor multimeric patter was normal, GP Ibc~ gene analysis was normal, and the ristocetin-°i nduced platelet agglutination was absent. Therefore, platelet-type von Willebrand disease could be ruled out in establishment of the diagnosis.
In this study, we reported a female patient with bleeding symptom from early in life, large platelets, and SPA. Several of the morphologic and laboratory findings are so different from those of any other hereditary giant platelet disorder in the literature, that we suppose it would probably represent a novel congenital platelet disorder that, to our knowledge, had not been found before. However, there are still many problems to be resolved.
First, its inheritance is not clear, since her parents were not consanguineous and their platelets appear unaffected. And the normal results of her GP MX gene analysis were invaluable for genetics study. It would seem to be an autosomal recessive trait. Second, the mechanism by which SPA occurred is unexplained, especially because it remained during administration of antiplatelet drugs such as aspirin and ticlopidine. Similar to this, interestingly, MPS platelets in calcium-free, fibrinogen-free buffer continue to show SPA (10) . Both of these phenomena could not be explained by the known mechanism of platelet activation, Considering the following three features, 1) no thrombotic complications, 2) no increased expression of P-selectin on resting platelet surface, and 3) no effect of therapy, we believe that SPA in this patient could preferably be attributed to platelet agglutination rather than real platelet activation. Third, the mechanism contributing to the abnormally large platelets in this patient is poorly understood. In Bernard-Soulier syndrome, the altered plasma membranecytoskeletal interaction due to GP IbIIX complex defect results to giant platelets (27) . However, analysis of GP :TbIT~ genes and their expression in platelet membrane of this patient were apparently normal. Finally, the anoma-lies of the thick membrane and large granules and their ' relation with the phenomenon of SPA are not yet understood. We hope that future research will clarify the molecular pathogenesis, of this case, and provide more information on platelet structure and function.
